Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001856491-26-000003
Filing Date
2026-04-29
Accepted
2026-04-29 16:20:55
Documents
1
Effectiveness Date
2026-04-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6693
  Complete submission text file 0001856491-26-000003.txt   7944
Mailing Address B5-19,BUILDING,HIGH-TECH INCUBATION PARK NO. 1480 NORTH SECTION OF TIANFU AVENUE CHENGDU F4 610041
Business Address B5-19,BUILDING,HIGH-TECH INCUBATION PARK NO. 1480 NORTH SECTION OF TIANFU AVENUE CHENGDU F4 610041 0086-28-8533-6966
Clover Biopharmaceuticals, Ltd. (Filer) CIK: 0001856491 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-582300 | Film No.: 26916439